DIABETES SGLT2 inhibitors and diabetic ketoacidosis - a growing concern

被引：20

作者：

Umpierrez, Guillermo E. ^{[1
]}

机构：

[1] Emory Univ, Sch Med, Endocrinol Metab & Lipids, 69 Jesse Hill Jr Dr, Atlanta, GA 30303 USA

来源：

NATURE REVIEWS ENDOCRINOLOGY | 2017年 / 13卷 / 08期

基金：

美国国家卫生研究院;

关键词：

COTRANSPORTER; 2; INHIBITOR; CANAGLIFLOZIN; OUTCOMES;

D O I：

10.1038/nrendo.2017.77

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diabetic ketoacidosis is a worrying complication associated with the use of sodium/glucose cotransporter 2 (SGLT2) inhibitors in patients with type 1 diabetes mellitus (T1DM) or T2DM. A recent analysis of data in the FDA Adverse Event Reporting System by Fadini and colleagues adds to this concern.

引用

页码：441 / 442

页数：2

共 50 条

[1] Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors
Rosenstock, Julio
Ferrannini, Ele
DIABETES CARE, 2015, 38 (09) : 1638 - 1642
[2] SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature
Burke, Kelly R.
Schumacher, Christine A.
Harpe, Spencer E.
PHARMACOTHERAPY, 2017, 37 (02): : 187 - 194
[3] Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis
Dutta, Siddhartha
Kumar, Tarun
Singh, Surjit
Ambwani, Sneha
Charan, Jaykaran
Varthya, Shoban B.
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (03) : 927 - 940
[4] A case series of diabetic ketoacidosis associated with SGLT2 inhibitors
Zac-Varghese, Sagen
Mathew, Sunitha
Go, Daniel
Winocour, Peter
PRACTICAL DIABETES, 2023, 40 (03) : 21 - +
[5] Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents
Wang, Yiting
Desai, Mehul
Ryan, Patrick B.
DeFalco, Frank J.
Schuemie, Martijn J.
Stang, Paul E.
Berlin, Jesse A.
Yuan, Zhong
DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 128 : 83 - 90
[6] Beware Ketoacidosis with SGLT2 Inhibitors in Latent Autoimmune Diabetes of the Adult
Nolan, Brendan J.
Varadarajan, Suresh
Fourlanos, Spiros
Neoh, Sandra L.
AMERICAN JOURNAL OF MEDICINE, 2020, 133 (08) : E422 - E424
[7] DIABETIC KETOACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES RECENTLY COMMENCED ON SGLT-2 INHIBITORS: AN ONGOING CONCERN
Ahmed, Mohamed
McKenna, Malachi J.
Crowley, Rachel K.
ENDOCRINE PRACTICE, 2017, 23 (04) : 506 - 508
[8] SGLT2 Inhibitors May Predispose to Ketoacidosis
Taylor, Simeon I.
Blau, Jenny E.
Rother, Kristina I.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (08) : 2849 - 2852
[9] Perioperative Ketoacidosis under SGLT2 Inhibitors
Buck, Sandra
Russo, Sebastian G.
ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2021, 56 (10): : 704 - 708
[10] SGLT2 Inhibitors as the Cause of the Development of Ketoacidosis
Emmelheinz, Markus
Roden, Michael
Muessig, Karsten
DIABETOLOGIE UND STOFFWECHSEL, 2019, 14 (06) : 439 - 442

← 1 2 3 4 5 →